INS and obesity disorder: There is consolidated evidence that obese PWS patients harbor a more favorable metabolic profile as compared to individuals with common obesity, including lower insulin levels, higher insulin sensitivity, increased adiponectin concentrations, as well as milder degrees of systemic inflammation and liver steatosis5–8.